Clinical Trials Logo

Filter by:
NCT ID: NCT04141865 Terminated - Clinical trials for Primary Open Angle Glaucoma

Effect of Xen Implantation on the Aqueous Humor Proteome

Start date: October 24, 2019
Phase:
Study type: Observational

The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma.

NCT ID: NCT04141046 Terminated - Depression Clinical Trials

LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of a type of non-invasive transcranial alternating current stimulation (tACS) on patients diagnosed with systemic lupus erythematosus (SLE) who are experiencing depression. Targeting depression in patients with SLE may provide benefit to these patients, as there is a clear relationship between chronic pain and depression. The investigators propose that a tACS stimulation montage that was previously used in depression could be beneficial to patients with SLE, resulting in reduced depression symptoms, thus resulting in reduced chronic pain and cognitive difficulties.

NCT ID: NCT04140695 Terminated - Atopic Dermatitis Clinical Trials

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Start date: October 21, 2019
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.

NCT ID: NCT04140669 Terminated - Clinical trials for Congenital Diaphragmatic Hernia

Automated Myocardial Performance Index Using Samsung HERA W10

Start date: September 16, 2019
Phase:
Study type: Observational

Researchers are using Myocardial performance index (MPI) to assess fetal cardiac function before, during, and after fetal surgery in order to gain more knowledge about fetal cardiac function in high risk pregnancies and the relationship to outcomes of fetal surgical interventions.

NCT ID: NCT04140396 Terminated - Rib Fractures Clinical Trials

Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia

Start date: February 10, 2020
Phase: Phase 4
Study type: Interventional

The current cornerstone of pain control for rib fractures is oral and intravenous opioids, especially in the form of patient-controlled analgesia (IV PCA), which are are associated with multiple adverse effects including sedation, respiratory depression, cough suppression, and increased risk of delirium. In the past few decades, intravenous lidocaine infusion (IVL) has emerged as a new tool in the arsenal of multimodal analgesia. Multiple randomized clinical trials have indicated that IVL is overall well tolerated and have shown other beneficial effects such as anti-inflammatory properties. To this date, there have been no published randomized clinical trials (RCT) evaluating the effectiveness of IVL in management of traumatic rib fracture pain. Therefore, the purpose of this study is to evaluate whether IV Lidocaine infusion can provide improved pain control as demonstrated by decreased OME consumption at 24 and 48 hours compared to placebo in adult patients with acute traumatic rib fractures.

NCT ID: NCT04140175 Terminated - Endometriosis Clinical Trials

A Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Due to Suspected or Confirmed Endometriosis and the Impact on the Disease or Symptom Progression.

Start date: January 20, 2020
Phase:
Study type: Observational

This study will describe historic, current, and evolving treatment pathways, treatments, and interventions in women with a suspected or confirmed diagnosis of endometriosis in order to better understand the impact of early intervention on the disease or its symptoms. Length of treatment is dependent on standard of care treatment provided and all study information will be collected during routine standard of care visits.

NCT ID: NCT04139993 Terminated - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

RBX7455 Before Surgery for the Treatment of Operable Breast Cancer

Start date: August 31, 2020
Phase: Phase 1
Study type: Interventional

This clinical trial studies the side effects and possible benefits of RBX7455 given before surgery in treating patients with breast cancer that can be removed by surgery (operable). RBX7455 contains live intestinal microbes (active drug), which are obtained from healthy human stool and may restore the normal balance of microorganisms in the intestines through the transplant of live and beneficial microorganisms.

NCT ID: NCT04139967 Terminated - Cancer, Rectal Clinical Trials

Study of Short Course Radiation Therapy for Elderly Patients With Rectal Cancer

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

This study will help determine if a short course of radiation therapy is effective to treat rectal cancer in older patients. A shorter course of radiation treatment may be better tolerated than a longer course or surgery for the treatment of rectal cancer in the elderly.

NCT ID: NCT04137770 Terminated - Pain, Postoperative Clinical Trials

Application of the ICE-T Postoperative Multimodal Pain Regimen to Laparoscopic Hysterectomy

Start date: February 4, 2020
Phase: N/A
Study type: Interventional

This is a randomized controlled trial evaluating whether application of ice packs and scheduled ketorolac to the surgical site after laparoscopic hysterectomy reduces need for narcotic medications.

NCT ID: NCT04136444 Terminated - Clinical trials for Healthy Study Participants

A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function

Start date: October 28, 2019
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the plasma pharmacokinetic (PK), safety and tolerability of padsevonil (PSL) in hepatically impaired and non-hepatically impaired study participants.